Literature DB >> 22694980

[Interaction brain-lungs].

L Abdennour1, C Zeghal, M Dème, L Puybasset.   

Abstract

The brain and the lungs interact early and rapidly when hit by a disease process. Often well tolerated by the healthy brain, an impaired respiratory function may deteriorate further a "sick" brain. Hypoxemia is a prognostic factor in the brain-injured patients. At the opposite, an acute brain damage early impacts the lung function. Local brain inflammation spreads rapidly to the lung. It initiates an immunological process weakening the lungs and increasing its susceptibility to infection and mechanical ventilation. Sometimes this process is preceded by a swelling lesion, known as neurogenic pulmonary oedema, resulting from an sympathetic overstimulation which usually follows an intense and brutal surge of intracranial pressure. The management of brain-injured patients has to be directed toward the protection of both the brain and lung. Neuronal preservation is crucial, because of the lack of regenerative potential in the brain, unlike the lung. A compromise must be obtained between the cerebral and pulmonary treatments although they may conflict in some situations.
Copyright © 2012. Published by Elsevier SAS.

Entities:  

Mesh:

Year:  2012        PMID: 22694980     DOI: 10.1016/j.annfar.2012.04.013

Source DB:  PubMed          Journal:  Ann Fr Anesth Reanim        ISSN: 0750-7658


  19 in total

Review 1.  Crosstalk Between Lung and Extrapulmonary Organs in Infection and Inflammation.

Authors:  Zhihan Wang; Qinqin Pu; Canhua Huang; Min Wu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation.

Authors:  Kiandokht Keyhanian; Raffaella Pizzolato Umeton; Babak Mohit; Vahid Davoudi; Fatemeh Hajighasemi; Mehdi Ghasemi
Journal:  J Neuroimmunol       Date:  2020-11-07       Impact factor: 3.478

Review 3.  COVID-19 Infection and Circulating Microparticles-Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease.

Authors:  Che Mohd Nasril Che Mohd Nassir; Sabarisah Hashim; Kah Keng Wong; Sanihah Abdul Halim; Nur Suhaila Idris; Nanthini Jayabalan; Dazhi Guo; Muzaimi Mustapha
Journal:  Mol Neurobiol       Date:  2021-06-26       Impact factor: 5.590

4.  Transient cortical blindness in COVID-19 pneumonia; a PRES-like syndrome: Case report.

Authors:  Yildiz Kaya; Simay Kara; Canan Akinci; Ayse Sagduyu Kocaman
Journal:  J Neurol Sci       Date:  2020-04-28       Impact factor: 3.181

Review 5.  Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates.

Authors:  Sajad Fakhri; Zeinab Nouri; Seyed Zachariah Moradi; Esra Küpeli Akkol; Sana Piri; Eduardo Sobarzo-Sánchez; Mohammad Hosein Farzaei; Javier Echeverría
Journal:  Molecules       Date:  2021-05-14       Impact factor: 4.411

6.  COVID-19 associated nervous system manifestations.

Authors:  Fatima Khatoon; Kartikay Prasad; Vijay Kumar
Journal:  Sleep Med       Date:  2021-07-09       Impact factor: 4.842

Review 7.  Neurological Involvement in COVID-19 and Potential Mechanisms: A Review.

Authors:  Ghazal Aghagoli; Benjamin Gallo Marin; Nicole J Katchur; Franz Chaves-Sell; Wael F Asaad; Sarah A Murphy
Journal:  Neurocrit Care       Date:  2021-06       Impact factor: 3.532

Review 8.  COVID-19 and the central nervous system.

Authors:  Safwan O Alomari; Zaki Abou-Mrad; Ali Bydon
Journal:  Clin Neurol Neurosurg       Date:  2020-08-04       Impact factor: 1.885

Review 9.  Nervous system involvement after infection with COVID-19 and other coronaviruses.

Authors:  Yeshun Wu; Xiaolin Xu; Zijun Chen; Jiahao Duan; Kenji Hashimoto; Ling Yang; Cunming Liu; Chun Yang
Journal:  Brain Behav Immun       Date:  2020-03-30       Impact factor: 7.217

Review 10.  Cerebrovascular and Neurological Dysfunction under the Threat of COVID-19: Is There a Comorbid Role for Smoking and Vaping?

Authors:  Sabrina Rahman Archie; Luca Cucullo
Journal:  Int J Mol Sci       Date:  2020-05-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.